National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

What You Need To Know About™

Melanoma

    Posted: 03/31/2003



Introduction






What Is Melanoma?






The Skin






Melanocytes and Moles






Understanding Cancer






Melanoma






Melanoma: Who’s at Risk?






Signs and Symptoms






Dysplastic Nevi






Diagnosis






Staging






Stages of Melanoma






Treatment






Getting a Second Opinion






Preparing for Treatment






Methods of Treatment






Surgery






Chemotherapy






Biological Therapy






Radiation Therapy






Treatment Choices by Stage






Recurrent Melanoma






Side Effects of Treatment






Surgery






Chemotherapy






Biological Therapy






Radiation Therapy






Nutrition






Followup Care






Support for People with Melanoma






The Promise of Cancer Research






How To Do a Skin Self-Exam






National Cancer Institute Booklets






National Cancer Institute Information Resources



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Order Free Copy
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Biological Therapy

Biological therapy (also called immunotherapy) is a form of treatment that uses the body’s immune system, either directly or indirectly, to fight cancer or to reduce side effects caused by some cancer treatments. Biological therapy for melanoma uses substances called cytokines. The body normally produces cytokines in small amounts in response to infections and other diseases. Using modern laboratory techniques, scientists can produce cytokines in large amounts. In some cases, biological therapy given after surgery can help prevent melanoma from recurring. For patients with metastatic melanoma or a high risk of recurrence, interferon alpha and interleukin-2 (also called IL-2 or aldesleukin) may be recommended after surgery.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov